{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:24:06Z","timestamp":1760239446091,"version":"build-2065373602"},"reference-count":12,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>Prognostic prediction has been reported to affect the decision of doctors and non-physician health care providers such as nurses, social workers, pastors, and hospice volunteers on the selection of appropriate medical interventions. This was a case of a 65-year-old woman who presented with a poor oral intake. The patient had a history of sigmoid colon cancer with abdominal wall metastasis and peritoneal dissemination. On the day of admission, nausea, anorexia, and malaise were noted, requiring immediate intervention. The patient\u2019s prognosis was predicted using the Palliative Prognostic Index. The pharmacist suggested the use of dexamethasone tablets in order to alleviate the patient\u2019s symptoms. Indeed, the administration of dexamethasone alleviated the symptoms of nausea, loss of appetite, and malaise. To the best of our knowledge, this is the first case report to demonstrate that prognosis prediction is important not only for other medical staff but also for pharmacists when deciding the need to initiate a treatment and continue such treatment, and when providing pharmacist interventions.<\/jats:p>","DOI":"10.3390\/pharmacy8040212","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T19:08:28Z","timestamp":1605121708000},"page":"212","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacist\u2019s Intervention Considering the Prognosis for a Terminal Cancer Patient: A Case Report"],"prefix":"10.3390","volume":"8","author":[{"given":"Masahiro","family":"Okada","sequence":"first","affiliation":[{"name":"Department of Pharmacy Onomichi Municipal Hospital, Shintakayama, Onomichi, Hiroshima 3-1170-177, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuko","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Onomichi Municipal Hospital, Shintakayama, Onomichi, Hiroshima 3-1170-177, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Surgery Onomichi Municipal Hospital, Shintakayama, Onomichi, Hiroshima 3-1170-177, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Sugihara","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Onomichi Municipal Hospital, Shintakayama, Onomichi, Hiroshima 3-1170-177, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiyoshi","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Onomichi Municipal Hospital, Shintakayama, Onomichi, Hiroshima 3-1170-177, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Onomichi Municipal Hospital, Shintakayama, Onomichi, Hiroshima 3-1170-177, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Onomichi Municipal Hospital, Shintakayama, Onomichi, Hiroshima 3-1170-177, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Onomichi Municipal Hospital, Shintakayama, Onomichi, Hiroshima 3-1170-177, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Banshoya","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Hiroshima 729-0292, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Onoda","sequence":"additional","affiliation":[{"name":"Department of Surgery Onomichi Municipal Hospital, Shintakayama, Onomichi, Hiroshima 3-1170-177, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisuke","family":"Takei","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Onomichi Municipal Hospital, Shintakayama, Onomichi, Hiroshima 3-1170-177, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuso","family":"Takeda","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Hiroshima 729-0292, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narumi","family":"Sugihara","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Hiroshima 729-0292, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0885-3924(01)00334-7","article-title":"Preparing for the end of life: Preferences of patients, families, physicians, and other care providers","volume":"22","author":"Steinhauser","year":"2001","journal-title":"J. Pain Symptom Manag."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0885-3924(02)00683-8","article-title":"Correlation of the dose of midazolam for symptom control with administration periods: The possibility of tolerance","volume":"25","author":"Morita","year":"2003","journal-title":"J. Pain Symptom Manag."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/annonc\/mdi121","article-title":"Association between hydration volume and symptoms in terminally ill cancer patients with abdominal malignancies","volume":"16","author":"Morita","year":"2005","journal-title":"Ann. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s005200050242","article-title":"The Palliative Prognostic Index: A scoring system for survival prediction of terminally ill cancer patients","volume":"7","author":"Morita","year":"1999","journal-title":"Support. Care Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.ejca.2015.04.025","article-title":"Survival prediction for advanced cancer patients in the real world: A comparison of the Palliative Prognostic Score, Delirium-Palliative Prognostic Score, Palliative Prognostic Index and modified Prognosis in Palliative Care Study predictor model","volume":"51","author":"Baba","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/082585979601200102","article-title":"Palliative Performance Scale (PPS): A new tool","volume":"12","author":"Anderson","year":"1996","journal-title":"J. Palliat. Care"},{"key":"ref_7","first-page":"751","article-title":"Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study","volume":"69","author":"Bruera","year":"1985","journal-title":"Cancer Treat. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s005200000218","article-title":"The use of corticosteroids in home palliative care","volume":"9","author":"Mercadante","year":"2001","journal-title":"Support. Care Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1200\/JCO.2012.44.4661","article-title":"Reduction of cancer-related fatigue with dexamethasone: A double-blind, randomized, placebo-controlled trial in patients with advanced cancer","volume":"31","author":"Yennurajalingam","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1089\/jpm.2011.0534","article-title":"Physician-reported corticosteroid therapy practices in certified palliative care units in Japan: A nationwide survey","volume":"15","author":"Matsuo","year":"2012","journal-title":"J. Palliat. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.327.7408.195","article-title":"A systematic review of physicians\u2019 survival predictions in terminally ill cancer patients","volume":"327","author":"Glare","year":"2003","journal-title":"BMJ"},{"key":"ref_12","first-page":"7","article-title":"Multidisciplinary Prognostication Using the Palliative Prognostic Score in an Australian Cancer Center","volume":"9","author":"Mendis","year":"2017","journal-title":"Palliat. Care"}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/8\/4\/212\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:31:57Z","timestamp":1760178717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/8\/4\/212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,11]]},"references-count":12,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["pharmacy8040212"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy8040212","relation":{},"ISSN":["2226-4787"],"issn-type":[{"type":"electronic","value":"2226-4787"}],"subject":[],"published":{"date-parts":[[2020,11,11]]}}}